← Leaderboards
Todd Jonathan Cohen
Univ Of North Carolina Chapel Hill
$9,633,113
Attributed
$17,111,086
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,111,086 · 14
By mechanism
R01$11,378,663 · 5
RF1$2,106,477 · 1
R21$1,715,269 · 4
R00$730,771 · 1
R56$656,733 · 1
R61$374,349 · 1
Top collaborators
- Douglas H. Phanstiel5 shared
- Jonathan C. Schisler5 shared
- Hyejung Won5 shared
- Graham Hugh Diering4 shared
- Antonio J. Planchart2 shared
- Laurie H Sanders2 shared
- Natalie M Stanley2 shared
- Giulia Fragola1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Marc Vermulst$7,260,572
- Jonathan C. Schisler$4,384,377
- Julie Christine Necarsulmer$159,281
- Baggio Angelo Evangelista$61,951
- Graham Hugh Diering$2,490,479
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseNerve DegenerationLinkDisease ProgressionNeuronsPathologyMouse ModelInsightBrainNeurodegenerative DisordersOnset Of IllnessInnovationTherapeutic TargetEventMediatingTau ProteinsResponsePathogenesisBehavioralTauopathiesModificationFunctional DisorderImpaired Cognition
Grant awards (34)
Environmental risk factors linked to TDP-43 proteinopathies$734,642
R01 · FY2025 · AG · contact PI
Sleep-dependent synaptic homeostasis in Alzheimer's disease$688,115
R01 · FY2025 · AG
The translational potential of next-generation sporadic mouse and human models of ALS/FTD$374,349
R61 · FY2025 · NS · contact PI
Spatial signatures of brain health and vulnerability in aging and Alzheimer's disease$189,241
R21 · FY2025 · AG · contact PI
Environmental risk factors linked to TDP-43 proteinopathies$772,621
R01 · FY2024 · AG · contact PI
Identifying Alzheimerâs Disease Causal Variants and Target Genes Using iPSC-derived Microglia$709,940
R01 · FY2024 · AG
Sleep-dependent synaptic homeostasis in Alzheimer's disease$702,159
R01 · FY2024 · AG
Spatial signatures of brain health and vulnerability in aging and Alzheimer's disease$225,245
R21 · FY2024 · AG · contact PI
Identifying kinase signaling pathways linked to tau-mediated neurodegeneration$197,813
R21 · FY2024 · AG · contact PI
Identifying Alzheimerâs Disease Causal Variants and Target Genes Using iPSC-derived Microglia$722,261
R01 · FY2023 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease$619,744
R01 · FY2023 · AG · contact PI
CRISPR gene therapies targeting tau in Alzheimer's disease and tauopathies$424,095
R21 · FY2023 · AG · contact PI
Identifying kinase signaling pathways linked to tau-mediated neurodegeneration$251,250
R21 · FY2023 · AG · contact PI
Identifying Alzheimerâs Disease Causal Variants and Target Genes Using iPSC-derived Microglia$738,776
R01 · FY2022 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease$619,744
R01 · FY2022 · AG · contact PI
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration$340,156
R01 · FY2022 · NS · contact PI
Sleep-dependent synaptic homeostasis in Alzheimer's disease$2,106,477
RF1 · FY2021 · AG
Identifying Alzheimerâs Disease Causal Variants and Target Genes Using iPSC-derived Microglia$751,779
R01 · FY2021 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease$619,744
R01 · FY2021 · AG · contact PI
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration$340,156
R01 · FY2021 · NS · contact PI
Identifying Alzheimerâs Disease Causal Variants and Target Genes Using iPSC-derived Microglia$758,870
R01 · FY2020 · AG
Sleep-dependent synaptic homeostasis in Alzheimer's disease$656,733
R56 · FY2020 · AG
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease$619,744
R01 · FY2020 · AG · contact PI
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration$340,156
R01 · FY2020 · NS · contact PI
Dual CHIP Functions Control Tau Triage In Alzheimer's Disease$619,744
R01 · FY2019 · AG · contact PI
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration$340,156
R01 · FY2019 · NS · contact PI
Dissecting the Role of HDAC6 in Alzheimer's Pathogenesis$194,375
R21 · FY2019 · AG · contact PI
Elucidating The Aberrant TDP-43 Species That Promote Neurodegeneration$340,156
R01 · FY2018 · NS · contact PI
Dissecting the Role of HDAC6 in Alzheimer's Pathogenesis$233,250
R21 · FY2018 · AG · contact PI
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies$238,169
R00 · FY2016 · NS · contact PI
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies$243,641
R00 · FY2015 · NS · contact PI
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies$248,961
R00 · FY2014 · NS · contact PI
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies$74,412
K99 · FY2013 · NS · contact PI
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies$74,412
K99 · FY2012 · NS · contact PI